Begelomab for severe refractory dermatomyositis: A case report

RATIONALE: Severe refractory idiopathic inflammatory myopathy (IIM) represents a challenge for the clinician. The lack of efficacy of available tools reflects our incomplete insight into the molecular events sustaining the inflammatory tissue damage in these patients. We present the first case of re...

Descripción completa

Detalles Bibliográficos
Autores principales: De Lorenzo, Rebecca, Sciorati, Clara, Monno, Antonella, Cavalli, Silvia, Bonomi, Francesco, Tronci, Stefano, Previtali, Stefano, Rovere-Querini, Patrizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
3600
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939186/
https://www.ncbi.nlm.nih.gov/pubmed/33655912
http://dx.doi.org/10.1097/MD.0000000000024372

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7939186/
https://www.ncbi.nlm.nih.gov/pubmed/33655912
http://dx.doi.org/10.1097/MD.0000000000024372

Ejemplares similares